Here's Why Investors Should Consider Selling NOV Stock Now

NOV Inc. shares have declined 22% over the past year, significantly underperforming peers and the broader sector, driven by a sharp 52% plunge in Q2 2025 net income to $108 million and a gross margin contraction to 20.4%. The company faces significant headwinds, including a 57% drop in new orders, a deteriorating 66% book-to-bill ratio, and downbeat Q3 2025 guidance, signaling future revenue softness and structural weakness in the North American market. This confluence of factors, along with persistent cost pressures and a lack of immediate recovery catalysts, suggests a fragile investment case and prompts a 'Sell' recommendation, as risks currently outweigh potential upside.

Analysis

NOV Inc. is exhibiting significant fundamental deterioration and market underperformance, with its shares declining 22% over the past year, in stark contrast to positive returns from its sub-industry, the broader energy sector, and key peers. The company's financial health is under pressure, demonstrated by a 52% year-over-year plunge in Q2 2025 net income to $108 million and a contraction in gross profit margin from 26.6% to 20.4%, attributed to a weaker sales mix, tariffs, and inflation. Forward-looking indicators are equally concerning; new orders collapsed by 57%, causing the book-to-bill ratio to fall to a bearish 66% from 177% a year prior, signaling a high probability of future revenue weakness. This is compounded by downbeat Q3 2025 guidance, which projects a 1-3% revenue decline and lower adjusted EBITDA, with management not anticipating a meaningful recovery in offshore activity until 2026. Furthermore, consensus earnings estimates for 2025 have been revised downward by 9.1% and indicate a 37.5% year-over-year decline, while estimates for peers like OIS and SEI show strong expected growth. The challenges appear structural, stemming from weakness in the core North American market, making NOV increasingly reliant on more volatile international projects.

Key Decisions for Investors

• Given the severe underperformance relative to peers, collapsing order book, and negative forward guidance, investors should consider reducing or exiting long positions in NOV as near-term catalysts for a recovery are absent.
• Monitor the book-to-bill ratio and gross margins in subsequent quarters; a sustained improvement above 100% and margin stabilization would be the first necessary signals of a potential turnaround.
• The stark performance divergence between NOV and peers such as Oil States International (OIS) and Solaris Energy (SEI) presents a potential pairs trade opportunity, going long the outperforming peers while shorting NOV to capitalize on opposing fundamentals.